Type Whole antibody ATC code none ChemSpider none | Source Humanized (from mouse) CAS Number 219649-07-7 | |
Target carcinoembryonic antigen | ||
Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5.
This drug was developed by Immunomedics, Inc.
References
Labetuzumab Wikipedia(Text) CC BY-SA